REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 59 filers reported holding REGULUS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $0 | -100.0% | 300 | -92.5% | 0.00% | – |
Q3 2017 | $5,000 | – | 4,000 | +1318.4% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 282 | -95.9% | 0.00% | – |
Q1 2017 | $11,000 | -42.1% | 6,874 | -19.1% | 0.00% | – |
Q4 2016 | $19,000 | +280.0% | 8,501 | +409.3% | 0.00% | – |
Q3 2016 | $5,000 | -68.8% | 1,669 | -70.0% | 0.00% | – |
Q2 2016 | $16,000 | -88.1% | 5,557 | -71.3% | 0.00% | – |
Q1 2016 | $134,000 | -48.7% | 19,364 | -35.2% | 0.00% | – |
Q4 2015 | $261,000 | +12950.0% | 29,893 | +11668.9% | 0.00% | – |
Q3 2015 | $2,000 | -99.6% | 254 | -99.5% | 0.00% | – |
Q2 2015 | $540,000 | +26900.0% | 49,274 | +54648.9% | 0.00% | – |
Q1 2015 | $2,000 | -96.8% | 90 | -97.7% | 0.00% | – |
Q4 2014 | $63,000 | +425.0% | 3,951 | +198.9% | 0.00% | – |
Q1 2014 | $12,000 | -89.6% | 1,322 | -91.5% | 0.00% | – |
Q4 2013 | $115,000 | +5650.0% | 15,592 | +8912.7% | 0.00% | – |
Q3 2013 | $2,000 | -95.8% | 173 | -96.5% | 0.00% | – |
Q2 2013 | $48,000 | – | 4,921 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |